Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
The outbreak of the COVID-19 pandemic has spread throughout the world, affecting almost all nations and territories. The current double-blind, randomized, placebo-controlled, phase II clinical trial sought to evaluate the clinical efficacy and safety of mebendazole as an adjuvant therapy for outpati...
Saved in:
Main Authors: | Mohamed El-Tanani (Author), Khaled Abdul-Aziz Ahmed (Author), Ashok K. Shakya (Author), Wesam G. Ammari (Author), Abdel-E (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of intestinal helminthiasis: mebendazole only or mebendazole-pyrantel pamoate?
by: Wisman Dalimunthe, et al.
Published: (2007) -
Luteal Phase Support in the Intrauterine Insemination (IUI) Cycles: A Randomized Double Blind, Placebo Controlled Study.
by: Batool Hossein Rashidi, et al.
Published: (2014) -
A double-blind placebo needle for acupuncture research
by: Takakura Nobuari, et al.
Published: (2007) -
Mebendazole vs. mebendazole-pyrantel pamoate for soil-transmitted helminthiasis infection in children
by: Fereza Amelia, et al.
Published: (2013) -
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)
by: Athanasios Tsianakas, et al.
Published: (2019)